图书简介
This fourth edition of the Oxford Textbook of Clinical Nephrology builds on the success and international reputation of the publication as an important resource for the practising clinician. It provides comprehensive, scholarly, and evidence-based coverage of the full spectrum of clinical nephrology, written by a global faculty of experts.
馆藏图书馆
Harvard Library
VOLUME 1; Part 1: Assessment of the patient with renal disease; 1 Aminu K. Bello, Marcello Tonelli, and Kitty J. Jager: Epidemiology of kidney disease; 2 Chris Winearls: Clinical assessment of the patient with renal disease; 3 Chris Winearls: Presentations of renal disease; 4 Chris Winearls: Kidney disease focused history taking; 5 Chris Winearls: Kidney disease focused features on examination; 6 Walter P. Mutter: Urinalysis; 7 Walter P. Mutter: Assessment of renal function; 8 Walter P. Mutter: Tubular function; 9 Michael Weston: Renal radiology: overview; 10 Jeannette Kathrin and Peter Howells: Ionising radiation and radiation protection; 11 Akira Kawashima and Andrew J. LeRoy: Plain radiography, excretion radiography, and contrast radiography; 12 Steven Kennish: Intervention; 13 Toby Wells and Simon Freeman: Ultrasound; 14 Eugene Teoh and Michael Weston: Computed tomography; 15 Kazuhiro Kitajima, Akira Kawashima. and James F Glockner: Magnetic Resonance Imaging; 16 Ramya Dhandapani and Sobhan Vinjamuri: Radioisotopes in diagnostic imaging in nephrology; 17 Jo H.M. Berden and Jack Wetzels: Immunological investigation of the patient with renal disease; 18 Ian Roberts, Phil Mason and Agnes Fogo: The renal biopsy; 19 Richard Haynes, Martin J Landry, William G Herrington, and Colin Baigent: Clinical trials- how and why in nephrology; Part 2: The patient with fluid, electrolyte, and renal tubular disorders; 20 Matthew A. Bailey: An overview of tubular function; 21 Laurent Schild: Sodium transport and balance: A key role for the distal nephron; 22 David Marples and Soren Neilson: Water homeostasis; 23 Alain Doucet and Gilles Crambert: Potassium homeostasis; 24 Carsten Wagner and Olivier Devuyst: Renal acid-base homeostasis; 25 Heini Murer, Juerg Biber, and Carsten Wagner: Phosphate homeostasis; 26 Francesco Trepiccione and Gianni Capasso: Calcium homeostasis; 27 Pascal Houillier: Magnesium homeostasis; 28 Ewout Hoorn and Bob Zietse: Approach to the patient with hyponatraemia; 29 Bob Zietse: Approach to the patient with hypernatraemia; 30 Jean-Marie Krzesinski and Eric P. Cohen: Approach to the patient with oedema; 31 Detlef Bockenhauer and Robert Kleta: Approach to the patient with salt-wasting; 32 Daniel Bichet: Approach to the patient with polyuria; 33 David Ellison and Arohan R. Subramanya: Clinical use of diuretics; 34 Charles Wingo and I. David Weiner: Approach to the patient with hypo-/hyperkalaemia; 35 Mitch Halperin and Kamel Kamel: Approach to the patient with metabolic acidosis or alkalosis; 36 Stephen Walsh: Approach to the patient with renal tubular acidosis; 37 Dennis Jose Joseph and Theresa A. Guise: Approach to the patient with hypercalcaemia; 38 Agnes Linglart and Anne-Sophie Lambert: Approach to the patient with hypocalcaemia; 39 Judith Blaine, Hector Giral-Arnal, Sabina Jelen, and Moshe Levi: Approach to the patient with hypo-/hyperphosphataemia; 40 Martin Konrad and Karl Peter Schlingmann: Approach to the patient with hypomagnesaemia; 41 Detlef Bockenhauer and Robert Kleta: Approach to the patient with renal Fanconi syndrome, glycosuria or aminoaciduria; Part 3: The patient with glomerular disease; 42 Alexander Woywodt and Diana Chiu: The glomerulus and the concept of glomerulonephritis; 43 Marlies Elger and Wilhelm Kriz: The renal glomerulus - the structural basis of ultrafiltration; 44 Jean-Claude Dussaule, Martin Flamant, and Christos Chatziantoniou: Function of the normal glomerulus; 45 Neil Turner: Mechanisms of glomerular injury: overview; 46 John Neary and Neil Turner: The patient with haematuria; 47 John Neary: Loin pain haematuria syndrome; 48 John Neary and Neil Turner: Nutcracker syndrome and phenomenon; 49 Neil Turner: Exercise-related pseudonephritis; 50 Neil Turner and Stewart Cameron: Proteinuria; 51 Neil Turner: Postural proteinuria (Benign orthostatic proteinuria); 52 Premil Rajakrishna, Stewart Cameron and Neil Turner: Nephrotic syndrome; 53 Neil Turner and Premil Rajakrishna: Pathophysiology of oedema in nephrotic syndrome; 54 Patrick Niaudet and Alain Meyrier: Idiopathic nephrotic syndrome: overview; 55 Patrick Niaudet and Alain Meyrier: Minimal change disease: clinical features and diagnosis; 56 Patrick Niaudet and Alain Meyrier: Minimal change disease: treatment and outcome; 57 Patrick Niaudet and Alain Meyrier: Primary focal segmental glomerulosclerosis (FSGS): Clinical features and diagnosis; 58 Patrick Niaudet and Alain Meyrier: Primary focal segmental glomerulosclerosis (FSGS): Treatment and outcome; 59 Patrick Niaudet and Alain Meyrier: Pathogenesis of proteinuria in minimal change disease and FSGS; 60 Daniel Cattran and Heather Reich: Membranous glomerulonephritis: overview; 61 Daniel Cattran and Heather Reich: Membranous glomerulonephritis: clinical features and diagnosis; 62 Daniel Cattran and Heather Reich: Membranous glomerulonephritis: treatment and outcome; 63 Daniel Cattran and Heather Reich: Secondary membranous glomerulonephritis; 64 Daniel Cattran and Heather Reich: Membranous glomerulonephritis: pathogenesis; 65 Kar Nen Lai and Sydney C. W. Tang: Immunoglobulin A nephropathy: overview; 66 Kar Nen Lai and Sydney C. W. Tang: Immunoglobulin A nephropathy: clinical features; 67 Kar Nen Lai and Sydney C. W. Tang: Immunoglobulin A nephropathy: diagnosis; 68 Kar Nen Lai and Sydney C. W. Tang: Immunoglobulin A nephropathy: treatment and outcome; 69 Kar Nen Lai and Sydney C. W. Tang: Immunoglobulin A nephropathy: pathogenesis; 70 Neil Turner: Crescentic (rapidly progressive) glomerulonephritis; 71 Ciao Zhou, Neil Turner, and Ming-hui Zhao: Anti-glomerular basement membrane disease: overview; 72 Ciao Zhou, Neil Turner, and Ming-hui Zhao: Anti-glomerular basement membrane disease: clinical features and diagnosis; 73 Ciao Zhou, Neil Turner, and Ming-hui Zhao: Anti-glomerular basement membrane disease: treatment and outcome; 74 Ciao Zhou, Neil Turner, and Ming-hui Zhao: Antiglomerular basement membrane disease: pathogenesis; 75 Neil Turner: Alport post-transplant antiglomerular basement membrane disease; 76 Bernardo Rodriguez-Iturbe and Mark Haas: Post-infectious glomerulonephritis: overview; 77 Bernardo Rodriguez-Iturbe and Mark Haas: Post streptococcal glomerulonephritis; 78 Bernardo Rodriguez-Iturbe and Mark Haas: Immunoglobulin A dominant post-infectious glomerulonephritis; 79 Bernardo Rodriguez-Iturbe and Mark Haas: Glomerulonephritis associated with endocarditis, deep-seated infections and shunt nephritis; 80 T. Cook and Daniel Gale: Membranoproliferative glomerulonephritis and C3 glomerulopathy; 81 Stephen Korbet, Melvin M.Schwartz, and Edmund J. Lewis: Fibrillary and immunotactoid glomerulopathy; 82 Alexander Woywodt and Diana Chiu: Drug induced and toxic glomerulopathies; Part 4: The patient with interstitial disease; 83 Richard Baker and B.Chir: Acute tubulointerstitial nephritis: overview; 84 Hassan Izzedine and Victor Gueutin: Drug-induced acute tubulointerstitial nephritis; 85 Gregory L. Braden and Benjamin J. Freda: Other toxic acute tubulointerstitial nephritis; 86 Adalbert Schiller, Adrian Covic, and Liviu Segall: Chronic tubulointerstitial nephritis: overview; 87 Hassan Izzedine and Victor Gueutin: Drug-induced chronic tubulointerstitial nephritis; 88 Patrick C D’Haese, Benjamin Vervaet, and A Verhulst: Heavy metals-induced tubulointerstitial nephritis; 89 Refik Gokmen and Graham Lord: Aristolochic acid nephropathy caused by ingestion of herbal medicinal products; 90 Milan Radovic and Adalbert Schiller: Balkan endemic nephropathy; 91 Lisa Phipps and David C. Harris: Radiation nephropathy; 92 D. H. Kang and M. Kanbay: Urate nephropathy; 93 Liviu Segall and Adrian Covic: Immune-mediated tubulointerstitial nephritis; Part 5: The patient with reduced renal function; 94 Ashish Upadyhah, Lesley Inker, and Andrew Levey: Chronic kidney disease: definition, classification, and approach to management; 95 Morgan Grams and Josef Coresh: Chronic kidney disease in the developed world; 96 LuXia Zhang and Haiyan Wang: Chronic kidney disease in developing countries; 97 M. Beaulieu, C. Weber, N. Zalunardo and Adeera Levin: Chronic kidney disease long-term outcomes: progression, death, cardiovascular disease, infections, and hospitalizations; 98 David Goldsmith: Cardiovascular disease and chronic kidney disease: overview; 99 Charles Ferro and Khai Ping Ng: Recommendations for management of high renal risk chronic kidney disease; 100 Teena Tandon and Rajiv Agarwal: Hypertension as a cause of chronic kidney disease: what is the evidence?; 101 Juan Jesus Carrero, Xu Hong, and Bengt Lindholm: Diet and the progression of chronic kidney disease; 102 Alan Jardine and Rajan Patel: Lipid disorders of patients with chronic kidney disease; 103 Stephan R. Orth: Smoking in chronic kidney disease; 104 Edmund Lamb and Finlay MacKenzie: Analytical aspects of measurements and laboratory values in chronic and acute kidney disease; 105 Andrew Williams, Robert Fassett, Erin Howden, and Jeff Coombes: Effect of lifestyle modifications on patients with chronic kidney disease; 106 Naveet Kumar, Peter McCulloch, Heather Henderson, and Beverly D. Cameron: Malnutrition, obesity, and undernutrition in chronic kidney disease; 107 Carmine Zoccali, Francesca Mallamaci, and Davide Bolignano: Left ventricular hypertrophy in chronic kidney disease; 108 Reza Hajhosseini, Kaivan Korvath, and David Goldsmith: Sudden cardiac death in chronic kidney disease; 109 Patrick Biggar, Hansjoerg Rothe, and Markus Ketteler: Epidemiology of calcium, phosphate and PTH disturbances in chronic kidney disease; 110 Juan Jesus Carrero and Peter Stenvinkel: The role of inflammation in chronic kidney disease; 111 John Townend and Charles Ferro: Vascular stiffness in chronic disease - pathophysiology and implications; 112 Nostratoli Vaziri: Oxidative stress and its implications in chronic disease; 113 Thimoteus Speer and Danilo Fliser: Abnormal endothelial vasomotor and secretory function; 114 Neeraj Dhaun and David Webb: Endothelins and their antagonists in chronic kidney disease; 115 Stuart Sprague and Menaka Sarav: Chronic kidney disease-mineral and bone disorder: overview; 116 Paulo Raggi and Luis D’Marco Gascon: Imaging for detection of vascular disease in chronic kidney disease patients; 117 Alexandra Voinescu, Nadia Iqbal and Kevin Martin: Pathophysiology of chronic kidney disease - mineral and bone disorder; 118 Alexandra Voinescu, Kevin Martin, Nadia Iqbal, and David Goldsmith: Management of chronic kidney disease - mineral and bone disorder; 119 Orlando Gutierrez: Fibroblast growth factor 23, klotho, and phosphorus metabolism in chronic kidney disease; 120 Adrian Covic, Mugurel Apetrii, Luminita Voroneanu, and David Goldsmith: Vascular calcification; 121 Alastair Hutchison and Michael L. Picton: Fractures in patients with chronic kidney disease; 122 Stuart Sprague and James Pullman: Spectrum of bone pathologies in chronic kidney disease; 123 Iain Macdougall: Clinical aspects and overview of renal anaemia; 124 Iain Macdougall and Jolanta Malyszko: Erythropoiesis-stimulating agents in chronic kidney disease; 125 Jolanta Malyszko and Iain Macdougall: Iron metabolism in chronic kidney disease; 126 Iain Macdougall: Iron management in renal anaemia; 127 Kaivan Khavandi, Halima Amer, Sarah Withers, and Behdad Afzali: Pleoitropic effects of Vitamin D; 128 Behdad Afzali and Claudia Kemper: Immunity; 129 Fabrizio Fabrizi and Michel Jadoul: The liver and chronic kidney disease; 130 Rishi Goel, Kamal Patel, and Terry Wong: Gastroenterology and renal medicine; 131 Timur A. Galperin, Kieron S. Leslie, and Antonia J. Cronin: Cutaneous manifestations of end-stage renal disease (ESRD); 132 Tomas Agustsson and Paul Carroll: The patient with reduced renal function: endocrinology; 133 Tomas Agustsson and Paul Carroll: Sexual dysfunction; 134 Fred Finkelstein and Susan Finkelstein: Health related quality of life and the patient with chronic kidney disease; 135 Seema Shrivastava, Beverley Hunt, and Tony Dorling: Coagulopathies in chronic kidney disease; 136 Neil Turner: Mechanisms of progression of chronic kidney disese- overview; 137 Jeremy Hughes: Proteinuria as a direct cause of progression; 138 Valerie Luyckx: Nephron numbers and hyperfiltration as drivers of progression; 139 Wilhelm Kriz: Podocyte loss as a common pathway to chronic kidney disease; 140 Jeremy Duffield: Disordered scarring and failure of repair; 141 Raj Thuraisingham and Cormac Breen: Modality selection for renal replacement therapy; 142 Sue Cox and Nicola Thomas: Patient education and involvement in pre-dialysis management; 143 Muh Geot Wong, Bruce A. Cooper, and Carol A. Pollock: Preparation for renal replacement therapy; 144 Karthik Tennankore and Chris Chan: Choices and considerations for in-centre versus home based renal replacement therapy; 145 Aine Burns and Fliss E.M. Murtagh: Conservative care in advanced chronic kidney disease; 146 Katie Vinen, Fliss E.M. Murtagh, and Irene Higginson: Palliative care in end stage renal disease; 147 Bernadette Thomas and Christopher Blagg: Patient selection when resources are limited; 148 Muhammad Magdi Yaqoob: Acidosis in chronic kidney disease; VOLUME 2; Part 6: The patient with another primary diagnosis; 149 Luigi Gnudi, Giorgio Gentile, and Piero Ruggenenti: The patient with diabetes mellitus; 150 Pierre M. Ronco: Kidney involvement in plasma cell dyscrasias; 151 Fabrizio Fabrizi and Patrice Cacoub: The patient with cryoglobulinaemia; 152 Helen J. Lachmann and Giampaolo Merlini: The patient with amyloidosis; 153 Efstathios Kastritis and M. A. Dimopoulos: The patient with myeloma; 154 Dirk R. J. Kuypers and Morie A. Gertz: Light chain deposition disease; 155 Fernardo Fervenza, S. Vincent Raj Kumar, and Sethi Sanjeev: Other consequences from monoclonal immunoglobulins/fragments: Membranoproliferative Glomerulonephritis and Acquired Fanconi Syndrome; 156 Ravi Rajakaria and Muhammad Magdi Yaqoob: The patient with sarcoidosis; 157 David Jayne: The patient with vasculitis- overview; 158 Peter Heeringa and Coen A. Stegeman: The patient with vasculitis: pathogenesis; 159 Alan Salama: The patient with vasculitis: clinical aspects; 160 Lorraine Harper and David Jayne: The patient with vasculitis: treatment and outcome; 161 Johan van der Vlag and Jo H.M. Berden: The patient with systemic lupus erythematosus: overview and pathogenesis; 162 Marie Condon, Philippa Dodd, and Liz Lightstone: The patient with systemic lupus erythematosus: clinical features, investigations, and diagnosis; 163 Frederic Houssiau: The patient with systemic lupus erythematosus: treatment and outcome; 164 Bassam Alchi and David Jayne: The patient with antiphospholipid syndrome with or without lupus; 165 Aine Burns and Bernadette Lynch: The patient with scleroderma-systemic sclerosis; 166 Lesley-Anne Bissell, Dwomoa Adu, and Paul Emery: The patient with rheumatoid arthritis, mixed connective tissue disease, polymyositis, Sjogren syndrome, or overlap syndrome; 167 Jean-Philippe Haymann and Francois Lionnet: The patient with sickle cell anemia; 168 Maarit Korkeila, Bengt Lindholm, and Peter Stenvinkel: The obese patient (metabolic syndrome); 169 Andres Cardenas and Pere Gines: The patient with hepatorenal syndrome; 170 Paul Goodyer: Kidney/ear syndromes; 171 Friederike Mackensen, Vedat Schwenger, and Heiko Billing: Kidney/eye syndromes; 172 Tim Eisen: The patient with renal cell cancer; 173 Christopher D. Mitchell: The patient with Wilms’ tumour; 174 Marina Noris and Tim Goodship: The patient with haemolytic uraemic syndrome/thrombotic thrombocytopenic purpura; Part 7: The patient with urinary tract infection; 175 Neil Sheerin: Urinary tract infection in the adult: overview; 176 Ased Ali and Rob Pickard: Infection of the lower urinary tract; 177 Mark Harber: Upper urinary tract infection; 178 Ased Ali and Rob Pickard: Complicated urinary tract infection; 179 Mark Harber: Urinary tract infection in a patient with a kidney transplant; 180 Heather Lambert: Urinary tract infection in infancy and childhood; 181 Rashad Barsoum: Schistosomiasis: the parasite and the host; 182 Rashad Barsoum: Schistosomiasis: clinical impact; Part 8: The patient with infections causing renal disease; 183 Vinay Sakhuja and Harbir Singh Kohli: Malaria; 184 Vinay Sakhuja and Harbir Singh Kohli: Leishmaniasis and trypanosomiasis; 185 Marion Muche and Seema Baid-Agrawal: Hepatitis B; 186 Fabrizio Fabrizi: Hepatitis C; 187 Saraladevi Naicker and Graham Paget: HIV and renal disease; 188 Hung-Chun Chen and Jan Clement: Hantaviral infections; 189 Jung-San Chang and Hung-Chun Chen: Dengue and other viral haemorrhagic fevers; 190 Norbert Lameire: Yellow fever, severe acute respiratory syndrome virus, and H1N1 influenza infections; 191 Emmanuel A. Burdmann: Leptospirosis; 192 Emmanuel A. Burdmann: Syphilis; 193 Emmanuel A. Burdmann and Vivekanand Jha: Rickettsiosis; 194 Rashad S. Barsoum: Schistosomiasis; 195 Raja Ramachandran and Vivekanand Jha: Nematode infections; 196 John Eastwood, Catherine M. Corbishley, and John M. Grange: Mycobacterial infections: tuberculosis; 197 John Eastwood, Catherine M. Corbishley, and John M. Grange: Mycobacterial infections: leprosy and environmental mycobacteria; 198 Raja Ramachandran and Vivekanand Jha: Renal involvement in other infections; Part 9: The patient with urinary stone disease; 199 Eric Taylor and Gary Curhan: Epidemiology of nephrolithiasis; 200 Bhavna Chopra and Stanley Goldfarb: Approach to the patient with kidney stones; 201 David A. Bushinsky and Orson Moe: Calcium stones; 202 Michel Daudon and Paul Jungers: Uric acid stones; 203 Michel Daudon and Paul Jungers: Cystine stones; 204 Benjamin A. Vervaet and Marc E. De Broe: Cell biology of nephrocalcinosis/nephrolithiasis; 205 Bridget Sinnott, Naim Maalouf, Khashayar Sakhaee, and Orson W. Moe: Medical management of nephrocalcinosis and nephrolithiasis; 206 Gauthier Raynal and Olivier Traxer: Imaging and interventional treatment: urolithiasis from the surgeon’s point of view; Part 10: The patient with hypertension; 207 Karlhans Endlich and Rodger Loutzenhiser: The structure and function of renal blood vessels; 208 Karlhans Endlich and Rodger Loutzenhiser: Regulation of vasomotor tone in the afferent and efferent arterioles; 209 Karlhans Endlich and Rodger Loutzenhiser: Tubuloglomerular feedback and autoregulation of renal blood flow and glomerular filtration rate; 210 O. Gonzalez-Albarrana and Luis M. Ruilopeb: The kidney and control of blood pressure; 211 Ulrich Wenzel, Thorsten Wiech, and Udo Helmchen: The effect of hypertension on renal vasculature and structure; 212 Helen Alderson, Constantina Chrysochou, James Ritchie, and Philip Kalra: Ischaemic nephropathy; 213 James Ritchie, Darren Green, Constantina Chrysochou, and Philip Kalra: Renal artery stenosis: clinical features and diagnosis; 214 James Ritchie, Darren Green, Constantina Chrysochou, and Philip Kalra: Renal artery stenosis: diagnosis; 215 James Ritchie, Darren Green, Constantina Chrysochou, and Philip Kalra: Renal artery stenosis: management and outcome; 216 Caroline Whitworth and Stewart Fleming: Malignant hypertension; 217 David Webb and Ian MacIntyre: Resistant hypertension; 218 Wolfgang Rascher: The hypertensive child; 219 Wolfgang Rascher: Treatment of hypertension in children; Part 11: The patient with acute kidney injury (and critical care nephrology); 220 Eric AJ Hoste and John A. Kellum: Definitions, classification, epidemiology, and risk factors of acute kidney injury; 221 Michael S. Goligorsky and Julien Maizel (with contributions by R Vasko, M Rabadi, and B Ratliff): Pathophysiology of acute kidney injury; 222 Norbert Lameire, Raymond Vanholder and Wim Van Biesen: Clinical approach to the patient with acute kidney injury: diagnosis and differential diagnosis; 223 Norbert Lameire: The role of novel biomarkers in acute kidney injury; 224 Norbert Lameire: Prevention of acute kidney injury: overview; 225 Norbert Lameire: Prevention
Trade Policy 买家须知
- 关于产品:
- ● 正版保障:本网站隶属于中国国际图书贸易集团公司,确保所有图书都是100%正版。
- ● 环保纸张:进口图书大多使用的都是环保轻型张,颜色偏黄,重量比较轻。
- ● 毛边版:即书翻页的地方,故意做成了参差不齐的样子,一般为精装版,更具收藏价值。
关于退换货:
- 由于预订产品的特殊性,采购订单正式发订后,买方不得无故取消全部或部分产品的订购。
- 由于进口图书的特殊性,发生以下情况的,请直接拒收货物,由快递返回:
- ● 外包装破损/发错货/少发货/图书外观破损/图书配件不全(例如:光盘等)
并请在工作日通过电话400-008-1110联系我们。
- 签收后,如发生以下情况,请在签收后的5个工作日内联系客服办理退换货:
- ● 缺页/错页/错印/脱线
关于发货时间:
- 一般情况下:
- ●【现货】 下单后48小时内由北京(库房)发出快递。
- ●【预订】【预售】下单后国外发货,到货时间预计5-8周左右,店铺默认中通快递,如需顺丰快递邮费到付。
- ● 需要开具发票的客户,发货时间可能在上述基础上再延后1-2个工作日(紧急发票需求,请联系010-68433105/3213);
- ● 如遇其他特殊原因,对发货时间有影响的,我们会第一时间在网站公告,敬请留意。
关于到货时间:
- 由于进口图书入境入库后,都是委托第三方快递发货,所以我们只能保证在规定时间内发出,但无法为您保证确切的到货时间。
- ● 主要城市一般2-4天
- ● 偏远地区一般4-7天
关于接听咨询电话的时间:
- 010-68433105/3213正常接听咨询电话的时间为:周一至周五上午8:30~下午5:00,周六、日及法定节假日休息,将无法接听来电,敬请谅解。
- 其它时间您也可以通过邮件联系我们:customer@readgo.cn,工作日会优先处理。
关于快递:
- ● 已付款订单:主要由中通、宅急送负责派送,订单进度查询请拨打010-68433105/3213。
本书暂无推荐
本书暂无推荐